Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma

Single-dose pegfilgrastim is comparable to daily filgrastim in mobilizing peripheral blood stem cells: a case-matched study in patients with lymphoproliferative malignancies

(2009) Mervi Putkonen et al.   ANNALS OF HEMATOLOGY

Treatment with Plerixafor in non-Hodgkin's Lymphoma and Multiple Myeloma Patients to Increase the Number of Peripheral Blood Stem Cells When Given a Mobilizing Regimen of G-CSF: Implications for the Heavily Pretreated Patient

(2009) Patrick Stiff et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Pharmacokinetics and Pharmacodynamics of Plerixafor in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma

(2009) Douglas A. Stewart et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Autologous transplantation for relapsed non-Hodgkin's lymphoma using intravenous busulfan and cyclophosphamide as conditioning regimen: a single center experience

(2009) M P Escalón et al.   BONE MARROW TRANSPLANTATION

Plerixafor

(2009) Antona J. Wagstaff   DRUGS

Modelling cost-effectiveness of high-dose chemotherapy as treatment for relapsed aggressive non-Hodgkin lymphoma in an Australian setting

(2009) J. Prajogo et al.   INTERNAL MEDICINE JOURNAL

Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin’s Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF

(2009) Fernando Callera et al.   TRANSFUSION AND APHERESIS SCIENCE

Management of poor peripheral blood stem cell mobilization: Incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions

(2009) Paolo Perseghin et al.   TRANSFUSION AND APHERESIS SCIENCE

Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation

(2008) Iskra Pusic et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells

(2008) C Hart et al.   BONE MARROW TRANSPLANTATION

Significance of low peripheral blood CD34+ cell numbers prior to leukapheresis: what should the threshold required for apheresis be?

(2008) A Gidron et al.   BONE MARROW TRANSPLANTATION

Current status of autologous hematopoietic stem cell transplantation in myeloma

(2008) J Mehta et al.   BONE MARROW TRANSPLANTATION

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma

(2008) M A Gertz et al.   BONE MARROW TRANSPLANTATION

Managing relapsed and refractory Hodgkin lymphoma

(2008) Pauline Brice   BRITISH JOURNAL OF HAEMATOLOGY

A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy

(2008) N. Russell et al.   HAEMATOLOGICA

Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy

(2008) G. Tricot et al.   HAEMATOLOGICA

Stem Cell Transplantation for Non-Hodgkin's Lymphoma

(2008) David Wrench et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Factors affecting autologous peripheral blood stem cell collection in patients with relapsed or refractory diffuse large cell lymphoma and Hodgkin lymphoma: A single institution result of 168 patients

(2008) Saad Akhtar et al.   LEUKEMIA & LYMPHOMA

DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients

(2008) Patrizia Zappasodi et al.   TRANSFUSION